Star Imaging and Path Lab secures MCD empanelment for diagnostics

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Star Imaging and Path Lab Limited secured empanelment with Municipal Corporation of Delhi
  • Diagnostic services will be provided at CGHS prescribed rates
  • Empanelment validity depends on continued CGHS status
  • Move aims to strengthen business and enhance service reach
powered bylight_fuzz_icon
53369179

*this image is generated using AI for illustrative purposes only.

Star Imaging and Path Lab Limited has been empanelled with the Municipal Corporation of Delhi (MCD) to provide diagnostic services to eligible beneficiaries. This development is expected to enhance the company's reach in the diagnostic sector.

The empanelment allows the company to offer services at Central Government Health Scheme (CGHS) prescribed rates. This move aligns with the company’s strategy to expand its footprint in government-linked healthcare projects.

Empanelment Details

The agreement was disclosed in a filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The key terms of the empanelment are outlined below:

Parameter Details
Partner Entity Municipal Corporation of Delhi (MCD)
Service Type Diagnostic services
Pricing Basis CGHS prescribed rates
Validity Condition Subject to continued validity of CGHS empanelment

The validity of this MCD empanelment remains contingent upon the continued validity of the company’s existing empanelment under CGHS and compliance with applicable terms and conditions. The company stated that this partnership is expected to further strengthen its business operations.

Historical Stock Returns for Star Imaging And Path Lab

1 Day5 Days1 Month6 Months1 Year5 Years
-1.06%+2.24%-7.37%+35.12%-42.72%-43.96%

How might this MCD empanelment influence Star Imaging's revenue mix and margin profile given the fixed CGHS prescribed rates?

What specific operational capacity expansions is Star Imaging planning to handle the anticipated increase in patient volume from MCD beneficiaries?

Could this successful partnership serve as a template for Star Imaging to secure similar empanelments with other municipal corporations or state health agencies?

Star Imaging And Path Lab
View Company Insights
View All News
like20
dislike

Star Imaging and Path Lab adopts FY26 financials at 22nd AGM

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Star Imaging and Path Lab Limited held its 22nd AGM on September 29, 2026
  • Shareholders adopted audited standalone and consolidated financial statements for FY26
  • Ms. Neelam Ratra was re-appointed as director following retirement by rotation
  • Meeting conducted via video conferencing with 10 shareholders attending virtually
powered bylight_fuzz_icon
52231671

*this image is generated using AI for illustrative purposes only.

Star Imaging and Path Lab Limited concluded its 22nd Annual General Meeting on September 29, 2026, adopting audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026.

The meeting was conducted through video conferencing and other audio-visual means, commencing at 2:00 pm and concluding at 2:17 pm. The requisite quorum was confirmed by the NSDL moderator with 10 shareholders attending virtually. All five directors of the company were present to oversee the proceedings.

Key resolutions passed

The shareholders considered and adopted two primary items of business as outlined in the notice of the meeting:

Resolution Type Details
Adoption of Financial Statements Ordinary Audited standalone and consolidated financial statements for FY26, along with Board and Auditor reports
Director Re-appointment Ordinary Appointment of Ms. Neelam Ratra (DIN: 11116532), retiring by rotation and eligible for re-appointment

Management commentary

Mr. Pawan Gupta, Chairman and Managing Director, delivered an opening address providing a comprehensive overview of the company's operational performance and strategic expansion during FY26. He highlighted key business achievements and outlined the broader business outlook for upcoming years.

Mr. Azad Ali, Chief Financial Officer, presented the financial highlights for FY25-26. He detailed revenue metrics and financial performance while outlining strategic growth initiatives aimed at enhancing revenue streams in the coming years. The CFO expressed gratitude to shareholders for their continued trust.

Procedural compliance

The company ensured full compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Remote e-voting was administered by National Securities Depository Limited (NSDL), running from September 26 to September 28, 2026. Ms. Sheetal, Partner of M/s. Sheetal & Co., Practicing Company Secretaries, served as the scrutinizer for the voting process.

The statutory registers and annual report were made available digitally to shareholders. The company secretary informed members that proxy appointments were not applicable due to the virtual format. Voting results will be submitted subsequently in accordance with Regulation 44(3) of the SEBI Listing Regulations.

Historical Stock Returns for Star Imaging And Path Lab

1 Day5 Days1 Month6 Months1 Year5 Years
-1.06%+2.24%-7.37%+35.12%-42.72%-43.96%

What specific strategic growth initiatives did CFO Azad Ali outline to enhance revenue streams in the coming years?

How does the company plan to expand its diagnostic services footprint given the Chairman's focus on strategic expansion during FY26?

Will the re-appointment of Ms. Neelam Ratra signal any changes in corporate governance or board composition strategies for Star Imaging and Path Lab?

Star Imaging And Path Lab
View Company Insights
View All News
like16
dislike

More News on Star Imaging And Path Lab

1 Year Returns:-42.72%